Moyco, Baby Boy .

HRN: 28-53-89  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/15/2026
AMPICILLIN 250MG (VIAL)
02/15/2026
02/22/2026
IV
141mg
Q12H
Neonatal Sepsis
Remove - Pending Acceptance
02/15/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/15/2026
02/22/2026
IV
42mg
Q24H
Neonatal Sepsis
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: